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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not virtual
reality training is effective in improving the quality of life for adults with Parkinson’s disease.
STUDY DESIGN: A systematic review of two randomized controlled trials (RCTs) and one
case series published between the years of 2017 and 2018.
DATA SOURCES: All articles were published in English and were taken from peer-reviewed
journals using CINAHL Plus. All articles were selected based on relevance to clinical question,
evaluation of patient-oriented outcomes, and date of publication.
OUTCOMES MEASURED: Each of the three articles analyzed the effects of virtual reality
training on improving quality of life (QOL) for adults with Parkinson’s disease. The Parkinson’s
Disease Questionnaire-39 (PDQ-39) and Parkinson’s Disease Questionnaire-8 (PDQ-8) were
used to measure quality of life, which were reported as mean change from baseline.
RESULTS: In the RCT conducted by Tollar et al., (J Cent Nerv Syst Dis. 2018;10:
1179573518813541. doi:10.1177/1179573518813541) researchers found that PDQ-39 scores did
improve following virtual reality rehabilitation (p<0.001). In the RCT by Gandolfi et al., (Arch
Phys Med Rehabil. 2018;99(12):247-2484.e1. doi: //doi.org/10.1016/j.apmr.2018.05.007.) there
was also significant improvement in the PDQ-8 scores before and after the intervention of virtual
reality training (p<0.001). However, the case series performed by Souza et al. (Fisioterapia em
Movimento. 2018;31. doi:10.1590/1980-5918.031.ao12.) showed insignificant findings in the
overall PDQ-39 scores after the intervention was implemented (p=0.135).
CONCLUSIONS: The three studies evaluated in this review provided inconclusive evidence on
whether or not virtual reality training is effective in improving quality of life for adults with
Parkinson’s disease. Tollar et al. (J Cent Nerv Syst Dis. 2018;10: 1179573518813541.
doi:10.1177/1179573518813541) and Gandolfi et al. (Archives of Physical Medicine and
Rehabilitation. 2018;99(12):247-2484.e1. doi: //doi.org/10.1016/j.apmr.2018.05.007.)
demonstrated a statistically significant improvement in quality of life whereas Souza et al.
(Fisioterapia em Movimento. 2018;31. doi:10.1590/1980-5918.031.ao12.) showed no
significance. Due to the conflicting results and limitations mentioned in each study, further
investigation is warranted to more effectively evaluate the effects of virtual reality rehabilitation
in improving quality of life for adults with Parkinson’s disease.
KEY WORDS: Parkinson’s, virtual reality, physical therapy
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INTRODUCTION
Parkinson’s disease is a progressive neurodegenerative disorder that occurs due to
deterioration of dopamine in the substantia nigra and degeneration of the basal ganglia, which
leads to a loss in control of voluntary movements. Although Parkinson’s disease has
conventionally been identified as a type of movement disorder, it is now considered a complex
disorder with additional neuropsychiatric and nonmotor manifestations.1 The progressive decline
of motor and cognitive functions can consequently result in adverse effects on an individual’s
independence and quality of life (QOL).2
As the second most-common neurodegenerative disorder in the US, the prevalence of
Parkinson’s disease in the US is 0.3% in the general population, 1-2% in persons over age 65,
and 4-5% in persons over age 85.1 The national economic burden of this condition is estimated to
be above $14.4 billion with the cost at approximately $22,800 per patient.1 In 2010, the
population of Parkinson’s disease patients incurred nearly 1.9 million hospital inpatient days and
1.26 million physician office visits.1 As the number of people living with neurological conditions
like Parkinson’s disease steadily rises with age, it is projected that the burden of the disease will
grow with the aging population.
It is well understood that the signs and symptoms of Parkinson’s disease are
predominately due to the loss of dopaminergic neurons in the midbrain. This disease is
characterized primarily by motor impairments including resting tremor, bradykinesia, rigidity,
and abnormal gait. Nonmotor clinical manifestations include, but are not limited to, cognitive
changes, psychosis, depression, anxiety, sleep disturbances, autonomic dysfunction, olfactory
issues, and gastrointestinal disturbances. As the diverse clinical features of the disease can vary
greatly between patients, it is important for healthcare clinicians to recognize the characteristic
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signs and symptoms in order to properly diagnose the condition and provide symptomatic
treatment early on to prevent mobility-related disability and comorbidities.3
While it is it is believed that Parkinson’s disease is a multifactorial neurodegenerative
process that occurs from a combination of factors such as aging, neuronal susceptibility, genetic
predisposition, and environmental exposures, the exact cause of disease is unknown.4 With that
being said, there is no standard treatment approach for patients.1 Nearly all available treatments
can provide symptomatic relief, however these interventions do not reverse the effects of the
disease. As mid-level practitioners, physician assistants working in the hospital and outpatient
setting must integrate various treatment modalities into their plan of care to help relieve
symptoms and maintain quality of life for patients.
Management of this condition with nonpharmacologic, pharmacologic, and/or surgical
therapy must be personalized to the needs of the individual patient. Non-pharmacologic
intervention involves lifestyle management with exercise, diet modifications, use of assisted
walking devices, speech therapy, and occupational therapy. Pharmacologic therapy is considered
the first-line treatment option for PD, which includes levodopa, dopamine agonists, MAO-B
inhibitors, and amantadine.4 Surgical options, such as pallidotomy and deep brain stimulation,
can be utilized in advanced disease refractory to pharmacological treatment.4
As mentioned previously, Parkinson’s disease patients can suffer from motor
impairments, such as postural instability and gait disturbances, which can adversely affect their
level of independence and quality of life.6 As postural instability is known to be refractory to
medications, rehabilitation is especially valuable in the management of Parkinson’s disease.3
Virtual reality therapy is an innovative approach to rehabilitation that is aided by gaming
technology in order to provide multisensory and complex exercise stimuli to participants. This

Le | Virtual Reality Training in Parkinson’s

3

therapy allows patients to engage in virtual reality scenarios by using their body movements to
control and play video games, which has been proven to be feasible and effective in neurological
conditions.3 It is thought that virtual reality training can help improve the quality of life for
Parkinson’s disease patients by promoting positive effects on posture and gait.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not “Is virtual
reality training effective in improving the quality of life for adults with Parkinson’s disease?”
METHODS
The articles utilized for this systematic review were found online via CINAHL Plus by
using the following key words: Parkinson’s, virtual reality, and physical therapy. Each study was
published in English in a peer-reviewed journal between the years of 2017 and 2018. These
sources were selected based on their relevance to the clinical question and evaluation of patientoriented outcomes (POEMs). Inclusion criteria for the studies included studies published after
2016. Exclusion criteria for the studies included studies published in 2016 or earlier. Summary of
statistics used in this review to determine clinical significance include p-value and mean change
from baseline.
The data sources of this systematic review specifically focused on the population of
adults with Parkinson’s disease. The three studies that were utilized for this review include two
randomized controlled trials (RCTs) and one case series. Each RCT compared the intervention
group of virtual reality training to two different control groups: no physical intervention and inclinic balance training. The case series did not compare the intervention to any control group.
The outcome that was measured in all three studies was quality of life.
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Table 1. Demographics and Characteristics of Included Studies
Study
Souza2
(2018)

Type
Case
Series

# of Pts
11

Gandolfi3 RCT
(2017)

76

Tollar6
(2018)

72

RCT

Age
65
±9.6

Inclusion Criteria
Patients with
modified Hoehn
and Yahr stages 13, normal or
corrected visual and
auditory acuity, no
previous
involvement with
Kinect system, and
no involvement in
an exercise program
within last 2
months.
67.45 Patients >18 years
±7.18 old, modified
Hoehn and Yahr
stages 2.5-3, steady
medication usage in
last month, ability
to perform postural
transfer and ability
to remain standing
posture for 10
minutes, and
presence of
caregiver.
67.6 Patients with Hoehn
±3.4 and Yahr stages 2-3
who are currently
taking Levodopa
equivalent
medications.

Exclusion Criteria
Patients who
presented with any
type of clinical deficit
that made it difficult
to perform standing
exercises like
cardiorespiratory,
orthopedic, or
neurological
problems.

W/D
0

Interventions
Virtual reality
using Xbox
Kinect
Adventures.

Patients with
cardiovascular,
orthopedic,
otovestibular
disorders, visual or
neurological
disorders, severe
dyskinesia, severe onoff fluctuations,
MMSE score <24/30,
or depression.

6

Home-based
virtual reality
tele-rehabilitation
vs. in-clinic
sensory
integration
balance training.

Patients with
9
cognitive deficits,
depression, severe
cardiovascular
disease, uncontrolled
DM, history of stroke,
traumatic brain injury,
seizure disorder, or
current involvement
in an exercise
program.

Virtual reality
training using
XboxTM vs. no
physical
intervention.
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OUTCOMES MEASURED
The patient-oriented outcome that was measured in each article was quality of life. Souza
et al. used the Parkinson Disease Questionnaire-39 (PDQ-39), a self-reported survey of 39
questions that assessed 8 domains: mobility, daily life activities, emotional state, stigma, social
support, cognition, communication, and body discomfort. Each domain was scored from 0 to
100, with a lower score representing a better perception of quality of life. Each participant
completed the PDQ-39 before treatment, immediately after treatment, and 30 days after
treatment, which was presented as mean differences before and after treatment. Tollar et al. also
utilized the PDQ-39 to measure quality of life scores in both groups before and after treatment.
The results of the PDQ-39 were reported as mean differences, with a change of 4.7 considered as
clinically significant.6 Gandolfi et al. used the Parkinson Disease Questionnaire-8 (PDQ-8) to
measure quality of life. The participants of this study completed the self-reported survey before
treatment, after treatment, and 1 month following treatment. The quality of life scores, presented
as mean values, were compared between the tele-rehabilitation group and the in-clinic
rehabilitation group, and also within each group overtime.
RESULTS
The case series performed by Souza et al. consisted of 11 participants between the ages of
48 to 76 years old, who had a diagnosis of Parkinson’s disease with stage 1 to 3 classification on
the Hoehn and Yahr Scale.2 This study, completed at the University of Sao Paulo in Brazil,
selected participants based on convenience for the study and inclusion criteria of normal or
corrected visual and auditory acuity, no previous involvement with Kinect system, and no
involvement in an exercise program within the last 2 months. Participants were excluded if they
presented with any cardiorespiratory, orthopedic, or other detectable neurologic disability, such
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as dementia or clinical signs of dyskinesia, due to the possibility that any clinical impairments
from these conditions might have negatively affected their ability to perform standing exercises.
In this study by Souza et al., each subject participated in a total of 14 one-hour sessions
(twice a week for 7 weeks) where they played 4 different games of Kinect Adventures on a
virtual-reality system via a X-Box gaming device.2 The games, selected based on motor and
cognitive demands, were completed 5 times with assistance by a physiotherapist. Patients were
not involved in any other type of rehabilitation during the period of the study. There were no
reports on safety, tolerability, or adverse effects of treatment.
The PDQ-39 assessed quality of life by evaluating the mean scores of 8 different domains
pre- and post- treatment with a p-value of <0.05 considered to be clinically significant.2 As
presented in Table 2, the only domain that demonstrated a substantial improvement was the
activities of daily living, in which there was a significant decrease of 8.7 in the pre-treatment
score to the 30-day post-treatment score (p<0.023).2 This improvement in daily activities was
attributed to the enhancement of postural control and cognition with the virtual reality games.2
The other seven domains plus the total PDQ-39 score demonstrated no significant change in
mean values pre- and post-treatment (p>0.05).2 Based on the results for all of the domains,
besides daily activities, the mean difference was lower than the value defined by the author.
Table 2. Mean (SD) Change in QOL and P-Values in a Study Conducted by Souza et al.2
Domain
Mobility
Activities of Daily Living*
Emotional Well Being
Stigma
Social Support
Cognition
Communication
Body Discomfort
Total
*P-value <0.05 is significant

Pre-Intervention
Mean (SD)
23.9 (27.5)
29.9 (22.7)
22.0 (22.8)
10.2 (15.6)
65.2 (5.0)
21.0 (13.8)
22.7 (25.8)
30.3 (23.9)
27.0 (11.9)

30 Days Post-Intervention
Mean (SD)
10.9 (9.6)
21.2 (21.8)
21.2 (15.0)
11.9 (17.3)
68.9 (5.4)
18.2 (15.9)
18.2 (21.0)
34.8 (25.8)
21.8 (8.2)

P-Value
0.328
0.023
0.794
0.692
0.135
0.248
0.446
0.682
0.135
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The multisite, single-blind RCT completed by Gandolfi et al. involved patients with
Parkinson’s disease and modified Hoehn and Yahr stages 2.5-3.3 Initially, there were 135
outpatients at 4 different neurorehabilitation units located in Veneto who were assessed for
eligibility. Inclusion criteria to participate included age >18 years old, modified Hoehn and Yahr
stages of 2.5-3, steady medication usage in last month, ability to perform postural transfer and
ability to remain standing posture for 10 minutes, and presence of a caregiver. Patients were
excluded if they had any cardiovascular, orthopedic, or otovestibular disorders; visual or
neurological disorders; severe dyskinesia or severe on-off fluctuations; Mini Mental State
Examination score <24/30; or depression. Of the original 135 patients, 26 patients were excluded
due to criteria stated above, 13 declined to participate, and 20 faced technological issues
preventing their participation.
The remaining 76 subjects in the study conducted by Gandolfi et al. were randomly
assigned by a computer-generated random number table into either the in-home virtual reality
tele-rehabilitation (TeleWii) group or the in-clinic sensory integration balance training (SIBT)
group.3 Two patients in the TeleWii group and four patients in the SIBT group withdrew from
the study due to medical reasons or transportation issues. Both groups participated in 21 sessions
of 50-minute rehabilitation. The TeleWii group consisted of balance exercises using the
Nintendo Wii Fit System, which was supervised by a physiotherapist. Under instruction and
support of a physical therapist, the SIBT group participated in 10 exercises aimed at improving
postural stability. Patients were not permitted to receive any other type of rehabilitation during
the period of the study. The study reported that there were no adverse events of either treatment,
however there was no information provided regarding safety or tolerability.
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In this study, mean values and standard deviation were used as descriptive statistics to
measure PDQ-8 scores before and after treatment and the level of significance was established at
p<0.025 for post hoc analysis.3 As shown in Table 3, both groups demonstrated an overall
improvement in outcomes measured before and after treatment.3 The TeleWii group had a
decrease of 4.9 from a pre-treatment mean of 30.72 to a post-treatment mean of 25.82 (p<0.001),
while the in-clinic group had a decrease of 6.62 from a pre-treatment mean of 30.53 to a posttreatment mean of 23.91 (p=0.016).3 However, there was no significant between-group
difference in PDQ-8 outcomes as measured by the post hoc analysis (p>0.025).3
Table 3. Mean (SD) Change in QOL and P-Values in a Study Conducted by Gandolfi et al.3

TeleWii**
In-Clinic**

Pre-Intervention
Mean (SD)

1 Month Post-Intervention
Mean (SD)

30.72 (15.54)
30.53 (16.04)

25.82 (14.89)
23.91 (13.20)

Post Hoc Analysis
P-Value
Within Groups
<0.001
0.016

Post Hoc Analysis
P-Value
Within Groups
>0.025

**For post hoc analysis, p-value <0.025 is significant

The RCT conducted by Tollar et al. involved patients with a diagnosis of Parkinson’s
with Hoehn and Yahr stages 2-3.6 Initially, 72 subjects were found by referrals from neurologists
in the area and by calling patients in the hospital’s database. Prior to the study, patients were
subjected to preliminary screening which included a full neurological examination, a gait and
posture examination, and an evaluation of cognitive function. Additionally, participants were
instructed to remain on levodopa medication therapy in order to lessen motor symptoms. Patients
were excluded if they presented with cognitive deficits, depression, severe cardiovascular
disease, uncontrolled DM, history of stroke, traumatic brain injury, seizure disorder, or current
involvement in an exercise program or deep brain stimulation. Exclusion criteria was instilled as
these factors could have possibly altered motor ability and therefore, response to treatment. Of
the 72 eligible participants, three were excluded for reasons stated above and five declined to
participate.
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The subjects in the study conducted by Tollar et al. were randomly allocated into a no
physical intervention control group or a high-intensity agility intervention group.6 Of the
remaining 64 patients who were randomly allocated to either the control or intervention group, 9
patients were excluded as they refused to be tested at baseline and withdrew from the study.
Patients in the intervention group underwent 15 one-hour sessions over 3 weeks, which included
4 parts that focused on postural instability and motor deficits: a warm-up, sensorimotor and
visuomotor agility training, sensorimotor agility training using virtual reality modules, and a
cool-down. These sessions were offered in the hospital’s physical therapy gym under supervision
of up to 3 physical therapists who implemented strict safety guidelines. Compliance was
measured through an attendance and symptom log, which showed 100% adherence to the
exercise program. The study did not provide reports on safety, tolerability, or adverse effects.
In this study, the results of the PDQ-39 were reported as mean differences, with a change
of 4.7 considered to be clinically significant and a level of clinical significance set at P<0.05.6 As
shown in Table 4, the intervention group improved in PDQ-39 outcomes before and after
treatment, while the control group did not improve.6 In the high-intensity agility group, there was
a 6.6-point decrease from the pre-intervention score of 30.0 to the post-intervention value of 23.4
(p<0.001).6 In comparison, the control group had a 0.2 increase from the pre-intervention score
of 30.6 and a post-intervention score of 30.8 (p>0.05).6 The difference between the mean values
of the intervention group before and after treatment was large and exceeded the 4.7-point
threshold, indicating a clinically significant reduction in quality of life.
Table 4. Mean (SD) Change in QOL and P-Values in a RCT Conducted by Tollar et al.6
Group
Intervention*
Control
*P-value <0.05 is significant

Pre-Intervention
Mean (SD)
30.0 (8.3)
30.6 (15.0)

Post-Intervention
Mean (SD)
23.4 (7.2)
30.8 (13.8)

P-Value
<0.001
>0.05

Le | Virtual Reality Training in Parkinson’s

10

DISCUSSION
The results of this study were conflicting as two studies presented statistically significant
results and one study had insignificant results. In the case series by Souza et al., there was no
statistical significant reduction in PDQ-39 scores besides in the daily activities domain.2
However, it has been shown that this specific domain is strongly associated with improving the
health of patients with Parkinson’s disease.2 In the RCT by Gandolfi et al., there was no
significant change between groups when comparing quality of life scores in the virtual reality
balance training to in-clinic balance training, but there were significant changes in the two
groups overtime.3 Nonetheless, this is clinically significant as the quality of life of PD patients
can improve regardless of treatment modality. The results of Tollar et al. showed significant
improvement in PDQ-39 outcomes in the intervention group, which were attributed to
improvement in motor symptoms.6
Each study acknowledged various limitations that may have affected the generalizability
and significance of the results. In the case series by Souza’s et. al, the small sample size, lack of
a control group, and great variability in disease stages of the participants may have limited the
outcomes of this study.2 Individuals in early stages of the disease without disabling symptoms
had a good perception of their quality of life prior to intervention, which may have limited their
ability to achieve significant improvements in their scores after treatment.2 Limitations in the
study conducted by Tollar et al. include lack of follow up post treatment and lack of
measurement of physical activity and diet modifications during treatment.6 Additionally, Tollar
et al. proposed that the Hawthorne effect may have swayed the results as participants could have
improved just from treatment and close observation.6
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While virtual reality programs have proven to be feasible and effective in improving
postural control, gait, and cognition in several neurological conditions, there are limitations of
this treatment. One limitation is the safety of virtual reality programs in patients due to potential
hazards of participation.3 It has been reported that virtual reality can result in adverse symptoms
like sickness, dizziness, and headache.7 Another limitation posed by Tollar et al. are policy issues
regarding reimbursement of therapy.6 Although virtual reality training has been proposed as a
cost-effective treatment, the cost of this new technology is high.7 Further investigation is
required to determine the costs associated with this novel rehabilitation program.
CONCLUSION
Based on the results of the two RCTs and one case series reviewed in this study, the
evidence is conflicting on whether or not virtual reality therapy is effective in improving quality
of life for adults with Parkinson’s disease. The case series by Souza et al. did not have significant
improvement in scores, which may have been influenced by the limitations of the study.2
However, in the two RCTs, there was a clinically meaningful reduction in PDQ scores in the
virtual reality intervention group, which holds potential for this therapy in the future.3,6 Further
studies are warranted with a larger variety of control groups, larger sample sizes, and longer
duration of treatment and follow up. Additionally, future research on treatment safety, adverse
effects, and tolerability is critical. As the projected burden of chronic conditions like Parkinson’s
disease continues to grow, there is an increased need for innovative treatment options to prevent,
delay onset, and alleviate symptoms of these conditions. Although virtual reality therapy opens
new opportunities for benefiting Parkinson’s disease patients, more rigorously designed
randomized controlled trials are needed to provide a stronger evidence-based basis to prove the
potential advantages.
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